Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 606

1.

Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.

Christante D, Pommier S, Givi B, Pommier R.

Surgery. 2008 Dec;144(6):885-93; discussion 893-4. doi: 10.1016/j.surg.2008.08.037.

PMID:
19040993
[PubMed - indexed for MEDLINE]
2.

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.

Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA.

Cancer J. 2003 Jul-Aug;9(4):261-7.

PMID:
12967136
[PubMed - indexed for MEDLINE]
3.

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.

Cancer. 2005 Oct 15;104(8):1590-602.

PMID:
16134179
[PubMed - indexed for MEDLINE]
Free Article
4.

Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.

Skinazi F, Zins M, Menu Y, Bernades P, Ruszniewski P.

Eur J Gastroenterol Hepatol. 1996 Jul;8(7):673-8.

PMID:
8853257
[PubMed - indexed for MEDLINE]
5.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
[PubMed - indexed for MEDLINE]
6.

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.

Ricci S, Antonuzzo A, Galli L, Ferdeghini M, Bodei L, Orlandini C, Conte PF.

Ann Oncol. 2000 Sep;11(9):1127-30.

PMID:
11061606
[PubMed - indexed for MEDLINE]
Free Article
7.

Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.

Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S.

Am J Clin Oncol. 2009 Dec;32(6):574-81. doi: 10.1097/COC.0b013e31819cca35.

PMID:
19636238
[PubMed - indexed for MEDLINE]
8.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
[PubMed - indexed for MEDLINE]
9.

Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.

Diaco DS, Hajarizadeh H, Mueller CR, Fletcher WS, Pommier RF, Woltering EA.

Am J Surg. 1995 May;169(5):523-8. Review.

PMID:
7747834
[PubMed - indexed for MEDLINE]
10.

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.

Strosberg JR, Choi J, Cantor AB, Kvols LK.

Cancer Control. 2006 Jan;13(1):72-8.

PMID:
16508629
[PubMed - indexed for MEDLINE]
Free Article
11.

[Surgical and adjuvant therapy of neuroendocrine tumors of the gastrointestinal tract and their metastases. A retrospective analysis of personal patient group].

Schmidbauer S, Ladurner R, J├╝ckstock H, Trupka AW, Mussack T, Hallfeldt KK.

Chirurg. 2001 Aug;72(8):945-52. German.

PMID:
11554141
[PubMed - indexed for MEDLINE]
12.

Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?

Hung JS, Chang MC, Lee PH, Tien YW.

World J Surg. 2007 Dec;31(12):2392-7.

PMID:
17960455
[PubMed - indexed for MEDLINE]
13.

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.

Drougas JG, Anthony LB, Blair TK, Lopez RR, Wright JK Jr, Chapman WC, Webb L, Mazer M, Meranze S, Pinson CW.

Am J Surg. 1998 May;175(5):408-12.

PMID:
9600289
[PubMed - indexed for MEDLINE]
14.

Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate.

Hajarizadeh H, Ivancev K, Mueller CR, Fletcher WS, Woltering EA.

Am J Surg. 1992 May;163(5):479-83.

PMID:
1374222
[PubMed - indexed for MEDLINE]
15.

[Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].

Zhao Y, Wang SM, Zhang J.

Ai Zheng. 2002 Apr;21(4):421-3. Chinese.

PMID:
12452025
[PubMed - indexed for MEDLINE]
16.

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.

Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB.

AJR Am J Roentgenol. 2007 May;188(5):1201-7.

PMID:
17449759
[PubMed - indexed for MEDLINE]
17.

Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.

Schell SR, Camp ER, Caridi JG, Hawkins IF Jr.

J Gastrointest Surg. 2002 Sep-Oct;6(5):664-70.

PMID:
12399054
[PubMed - indexed for MEDLINE]
18.

Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.

Diamandidou E, Ajani JA, Yang DJ, Chuang VP, Brown CA, Carrasco HC, Lawrence DD, Wallace S.

AJR Am J Roentgenol. 1998 Feb;170(2):339-44.

PMID:
9456942
[PubMed - indexed for MEDLINE]
19.

Transcatheter therapy of gastric cancer metastatic to the liver: preliminary results.

Tarazov PG.

J Gastroenterol. 2000 Dec;35(12):907-11.

PMID:
11573726
[PubMed - indexed for MEDLINE]
20.

Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.

Kim YH, Ajani JA, Carrasco CH, Dumas P, Richli W, Lawrence D, Chuang V, Wallace S.

Cancer Invest. 1999;17(7):474-8.

PMID:
10518191
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk